¼¼°èÀÇ ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå : ¸ðºô¸®Æ¼º°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Skin Perfusion Pressure Testing Devices Market, By Mobility, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1663464
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 301 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,715,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,746,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,197,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 18¾ï 5,160¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025-2032³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 9.60%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå - ½ÃÀå ¿ªÇÐ

Àúħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ È¯ÀÚ ¼±È£µµ Áõ°¡

ÇǺΰü·ù¾Ð °Ë»ç Àåºñ ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼öÇý¸¦ ¹ÞÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µé°ú ³ëÀÎ Àα¸°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ »ó´çÇÑ È¯ÀÚ ±â¹ÝÀÌ Çü¼ºµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÃÖ¼Òħ½À¼ö¼úÀÇ Àαâ´Â ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ÀÌÁ¡À» Á¦°øÇϱ⠶§¹®¿¡ Á¡Á¡ ´õ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÛÀº Àý°³Ã¢, ÀûÀº ÅëÁõ, ÀûÀº Á¶Á÷ ¼Õ»ó, ¼ö¼ú ÈäÅÍ ¾øÀ½, ºü¸¥ ȸº¹, °¨¿° À§Çè °¨¼Ò, ªÀº ÀÔ¿ø ±â°£ µî ħ½ÀÀû ¼ö¼ú¿¡ ºñÇØ ÀåÁ¡ÀÌ ¸¹±â ¶§¹®¿¡ ȯÀÚµéÀÇ ¼±È£µµ°¡ Àúħ½À ¼ö¼ú·Î À̵¿Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº °³º¹ ¼ö¼ú·Î ÀÎÇÑ °íÅëÀ» ÁÙÀ̰í, °¡Àå Áß¿äÇÑ °ÍÀº ½ÅüÀû »óÇØ¿Í ¼ö¼úÀ» ¿¹¹æÇÏ¿© ȯÀÚ¿Í ÀÇ»ç ¸ðµÎ¿¡°Ô µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ÀÇ·á°è¿¡¼­ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÇǺΰü·ù¾Ð °Ë»ç ÀåÄ¡¸¦ »ç¿ëÇÏ¸é ºÒÆí°¨ °¨¼Ò, Àú·ÅÇÑ ¼ö¼ú ºñ¿ë, µå¹® »óȲ¿¡¼­ÀÇ °æ¹ÌÇÑ ÇÕº´Áõ µîÀÇ ÀÌÁ¡ÀÌ ÀÖ¾î ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 9.60%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¸ðºô¸®Æ¼ ¼¼ºÐÈ­¿¡ µû¶ó ÀÚµ¿Â÷ ±â¹Ý µð¹ÙÀ̽º Ä«Å×°í¸®°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ë ¼¼ºÐÈ­¿¡ µû¶ó 2024³â º´¿øÀÌ ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â¿¡ ¼öÀÍÀ» âÃâÇÒ ÁÖ¿ä ½ÃÀåÀ¸·Î ²ÅÇû½À´Ï´Ù.

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ¼¼°è ½ÃÀåÀº À̵¿¼º, Á¦Ç°, ÃÖÁ¾ ¿ëµµ, Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

À̵¿¼ºÀ» ±â¹ÝÀ¸·Î ½ÃÀåÀº īƮ ±â¹Ý ÀåÄ¡¿Í ÈÞ´ë¿ë ÀåÄ¡·Î ³ª´µ¸ç, 2024³â¿¡´Â īƮ ±â¹Ý ÀåÄ¡ Ä«Å×°í¸®°¡ ¾ÐµµÀûÀÎ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. īƮÇü ±â±â´Â °íÁ¤ÇüÀ̸ç, Àü¹® Ŭ¸®´ÐÀ̳ª º´¿ø¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖ½À´Ï´Ù. ±¤¹üÀ§ÇÑ Ç÷°ü Æò°¡ ±â´É°ú ÇÔ²² °í±Þ ±â´É°ú ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ´õ Å« È­¸é, Áß¿äÇÑ µ¥ÀÌÅÍ ÀúÀå ±â´ÉÀ» °®Ãß°í ÀÖÀ¸¸ç, Á¾Á¾ ´Ù¸¥ Áø´Ü ¹æ½Ä°ú °áÇյǾî Àǻ翡°Ô Ç÷°ü °Ë»ç¸¦ À§ÇÑ ¿Ïº®ÇÑ Ç÷§ÆûÀ» Á¦°øÇÕ´Ï´Ù. īƮ ±â¹Ý Àåºñ´Â Àǻ簡 Á¤È®ÇÑ Áø´Ü°ú Ä¡·á °èȹÀ» ¼¼¿ì´Â µ¥ ÇÊ¿äÇÑ ¸®¼Ò½º¸¦ Á¦°øÇϸç, »ó¼¼ÇÑ Æò°¡¿Í º¹ÀâÇÑ Ä¡·á¿¡ ÀÌ»óÀûÀÔ´Ï´Ù.

Á¦Ç°º°·Î ½ÃÀåÀº ·¹ÀÌÀú µµÇ÷¯, ÃÊÀ½ÆÄ, ±¤Àü ±ÙÀüµµ, ±âŸ·Î ºÐ·ùµÇ¸ç, 2024³â¿¡´Â ·¹ÀÌÀú µµÇ÷¯ Ä«Å×°í¸®°¡ ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¶Á÷ °ü·ù¸¦ Á¤È®Çϰí Á¤·®ÀûÀ¸·Î Æò°¡Çϱâ À§ÇØ ·¹ÀÌÀú µµÇ÷¯ ÇǺΠ°ü·ù ¾Ð·Â °Ë»ç Àåºñ´Â µµÇ÷¯ È¿°ú¸¦ ÀÌ¿ëÇÏ¿© Ç¥À缺 Á¶Á÷ÀÇ Ç÷·ù ¼Óµµ¸¦ Á¤·®È­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¹Ý»çµÈ ·¹ÀÌÀú ºûÀÇ Á֯ļö º¯È­¿¡ µû¸¥ ¹Ì¼¼ ¼øÈ¯ÀÇ °´°üÀûÀÎ ÃøÁ¤°ªÀ» ÀÓ»óÀÇ¿¡°Ô Á¦°øÇÔÀ¸·Î½á Ç÷°ü ÁúȯÀÇ Á¶±â ¹ß°ß ¹× Ä¡·á ÁöħÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ·¹ÀÌÀú µµÇ÷¯¸¦ »ç¿ëÇÏ´Â Àåºñ´Â ÇãÇ÷¼º »çÁö³ª ¸¸¼º »óó¿Í °°ÀÌ Ç÷¾× °ø±ÞÀÌ Á¦ÇÑµÈ ºÎÀ§ÀÇ °ü·ù ÆÇ´Ü¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-Áö¸®Àû ÅëÂû·Â

2024³â¿¡´Â ºÏ¹Ì°¡ ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ¼¼°è ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÏ¹Ì´Â °¡Àå ¹ßÀüµÈ ÇコÄÉ¾î ½ÃÀå Áß ÇϳªÀ̱⠶§¹®¿¡ ÇǺΰü·ù¾Ð °Ë»ç ÀåºñÀÇ ±â¼ú Çâ»ó°ú º¸±Þ·ü ¸ðµÎ¿¡¼­ ¼¼°è¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â Ç÷°ü Áúȯ°ú ¸¸¼º »óóÀÇ ºóµµ°¡ ³ô±â ¶§¹®¿¡ ÷´Ü Áø´Ü ÀåºñÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ª ½ÃÀå È®´ë´Â °­·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó, À¯¸®ÇÑ »óȯ Á¤Ã¥, ÀÇ·áºñ Áõ°¡¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.

±×·¯³ª ¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡¿¡¼­ ½ÉÀ庴°ú ´ç´¢º´ÀÇ À¯º´·ü Áõ°¡¿¡ ÈûÀÔ¾î °¡Àå ºü¸¥ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼­ ÇǺΰü·ù¾Ð °Ë»ç ÀåºñÀÇ »ç¿ëÀº ÀÇ·á ÅõÀÚ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼±, Ç÷°ü °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¹æ´ëÇÑ È¯ÀÚ ±â¹Ý°ú ¹Ì°³Ã´ ½ÃÀå Àü¸ÁÀÌ ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÇǺΰü·ù¾Ð °Ë»ç±â ½ÃÀå - °æÀï ±¸µµ:

ÇǺΰü·ù¾Ð °Ë»ç Àåºñ ¼¼°è ½ÃÀå¿¡¼­´Â Viasonix, Moor Instruments, Vasamed, ELCAT, CorVascular Diagnostics¿Í °°Àº À¯¸í ±â¾÷µé °£¿¡ Ä¡¿­ÇÑ °æÀïÀÌ ¹ú¾îÁö°í ÀÖ½À´Ï´Ù. »óó ¹× Ç÷°ü Áúȯ Ä¡·á¿¡ ÀÖ¾î Á¤¹Ð Áø´Ü ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ À̵é ÁÖ¿ä ¾÷üµéÀº ÇǺΠ°ü·ù¾Ð ÃøÁ¤ Á¦Ç° ¶óÀÎÀ» °³¼±Çϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀÌ Áö¸®Àû ¹üÀ§¿Í Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇØ Á¦ÈÞ, ÇÕº´, Àμö µî ½ÃÀå È®Àå Àü¼úÀ» »ç¿ëÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ ½ÃÀåÀÇ °æÀï ȯ°æÀº ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ±â¼ú °³¹ßÀÇ ¿µÇâÀ» Å©°Ô ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â ÇコÄÉ¾î ¼º°ú Çâ»ó¿¡ ´ëÇÑ Çå½ÅÀûÀÎ ³ë·ÂÀ» º¸¿©ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù, Ç¥ÇÇ Ç÷·ù ¸ð´ÏÅ͸µ ÀåÄ¡¸¦ °³¹ßÇÑ ½º¿þµ§ÀÇ PeriMed AB´Â Smith & Nephew(¿µ±¹)¿¡ ÀμöµÇ¾ú½À´Ï´Ù. ÀÌ Àμö¸¦ ÅëÇØ Smith & NephewÀÇ ÇöÀç »óó °ü¸® Á¦Ç° ¹× ±â¼ú ¶óÀÎÀÌ °­È­µÇ°í ÀÇ·á »ê¾÷¿¡¼­ Á¦°øµÇ´Â ǰ¸ñÀÌ È®´ëµÇ¾ú½À´Ï´Ù.

ÃÖ±Ù µ¿Çâ

2024³â 2¿ù: ºÏÀ¯·´ÀÇ ´ëÇü ÇコÄɾî ÅõÀÚÀÚ Serendipity Partners°¡ Ç÷°ü ÀÇ·á±â±â ½ÃÀåÀÇ Àú¸íÇÑ ¸®´õÀÎ Perimed ABÀÇ ÁöºÐ 49%¸¦ ´ëÆø ÀμöÇß½À´Ï´Ù. ÀÌ´Â Perimed ABÀÇ Áß¿äÇÑ ÀÌÁ¤Ç¥°¡ µÉ °ÍÀÔ´Ï´Ù. À̹ø Á¦ÈÞ´Â PerimedÀÇ Áö¼ÓÀûÀÎ °³¹ß°ú Á¦Ç° È®ÀåÀ» º¸ÀåÇÒ °ÍÀÔ´Ï´Ù.

2023³â 1¿ù: MicroPort Scientific Corporation(Áß±¹)ÀÌ ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±âÀÇ ¼±µÎ Á¦Á¶¾÷üÀÎ Vasamed(½º¿þµ§)¸¦ ÀμöÇß½À´Ï´Ù. À̹ø Àμö·Î MicroPort´Â VasamedÀÇ ÃÖ÷´Ü Á¦Ç° ¶óÀο¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®º¸ÇÏ¿© »óó Ä¡·á ¾÷°è¿¡¼­ ÀÔÁö¸¦ È®°íÈ÷ Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â »ê¾÷ Á¶»ç

Á¦5Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå ±¸µµ

Á¦7Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-¸ðºô¸®Æ¼º°

Á¦8Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-Á¦Ç°º°

Á¦9Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-ÃÖÁ¾ ¿ëµµº°

Á¦10Àå ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ½ÃÀå-Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼®-ÇǺΰü·ù¾Ð(SPP) °Ë»ç ±â±â ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Skin Perfusion Pressure Testing Devices Market size was valued at US$ 1,851.6 Million in 2024, expanding at a CAGR of 9.60% from 2025 to 2032.

Skin perfusion pressure testing has become a precise way to determine how much blood is getting to the damaged tissue. The relaxation of carefully regulated occlusion must be prioritized in order to restore normal microcirculatory blood flow, which requires skin perfusion pressure (SPP). Devices for skin perfusion pressure testing are minimally invasive tools used to measure blood flow rate and assess segmental blood pressures, such as the ankle-brachial index (ABI). In order to diagnose peripheral artery illnesses such as critical limb ischemia and to determine the best level of amputation, among other things, skin perfusion pressure devices are widely used. Key factors driving the global skin perfusion pressure testing devices market include deep penetration channels for distribution of these devices to a variety of end-user segments, including hospitals and ambulatory surgical centres, which provide better access in developed markets; growing demand for the newest skin perfusion pressure testing devices; and manufacturers' shifting focus on creating better devices. Skin perfusion pressure is a non-invasive diagnostic technique that measures systolic pressure in microcirculation and quantitatively examines blood flow. Additionally, patients with peripheral arterial disease (PAD) and diabetes are frequently advised to undergo skin perfusion pressure testing; their rising incidence will increase market demand for skin perfusion pressure testing equipment.

Skin Perfusion Pressure Testing Devices Market- Market Dynamics

Increasing patient preferences for minimally invasive procedures

The skin perfusion pressure testing devices market would benefit from rising demand for minimally invasive operations because the number of people with chronic illnesses, such as diabetes, and the elderly population has been growing, which has created a sizable patient base. The popularity of minimally invasive operations is growing due to the advantages they offer both patients and medical professionals. Patients' preferences have shifted in favour of minimally invasive surgeries because of their advantages over invasive procedures, including smaller incisions, less pain, less tissue damage, the avoidance of surgical scars, quicker recovery, fewer risks of infection, and shorter hospital stays. These methods are becoming more and more popular in the medical world since they help patients and doctors alike by reducing the agony that open operations cause and, most importantly, preventing bodily harm and surgery. The benefits of using skin perfusion pressure testing devices, such as reduced discomfort, cheaper surgical expenses, and minor complications in rare situations, are anticipated to support market growth in the upcoming years.

Skin Perfusion Pressure Testing Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.60% over the forecast period (2025-2032)

Based on mobility segmentation, the car-based devices category was predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Skin Perfusion Pressure Testing Devices Market- Segmentation Analysis:

The Global Skin Perfusion Pressure Testing Devices Market is segmented on the basis of Mobility, Product, End Use, and Region.

Based on mobility, the market is divided into Cart-based devices and Portable devices. In 2024, the cart-based devices category held a dominant market share. Cart-based devices are stationary units that are commonly found in specialized clinics and hospitals. They offer advanced features and functionalities along with extensive vascular evaluation capabilities. These devices provide doctors with a full platform for vascular examination since they have larger screens, significant data storage capabilities, and are frequently coupled with other diagnostic modalities. Cart-based devices give physicians the resources they need for precise diagnosis and treatment planning, making them ideal for in-depth evaluations and intricate treatments.

On the basis of product, the market is segregated into Laser doppler, Ultrasound, Photoplethysmography, and Others. In 2024, the market was dominated by the laser doppler category. In order to provide accurate and quantitative evaluations of tissue perfusion, laser Doppler skin perfusion pressure testing devices use the Doppler effect to quantify blood flow velocity in superficial tissues. These technologies enable early identification of vascular impairment and guide treatment measures by giving clinicians objective measurements of microcirculation based on changes in the frequency of reflected laser light. Devices that use laser Doppler are especially useful for determining perfusion in areas with a restricted blood supply, like ischemic limbs and chronic wounds.

Skin Perfusion Pressure Testing Devices Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Skin Perfusion Pressure Testing Devices. North America leads the world in both technological improvements and the adoption rates of skin perfusion pressure testing devices because it is one of the most developed healthcare markets. The high frequency of vascular illnesses and chronic wounds in the area fuels the need for sophisticated diagnostic equipment. Furthermore, this region's market expansion is supported by a strong healthcare infrastructure, advantageous reimbursement policies, and rising healthcare spending.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by the rising incidence of heart disease and diabetes, especially in nations like China and India. The use of skin perfusion pressure testing equipment in this region is influenced by rising healthcare investments, bettering healthcare infrastructure, and increased vascular health awareness-additionally, a sizable patient base and unexplored market prospects fuel market expansion in the Asia Pacific region.

Skin Perfusion Pressure Testing Devices Market- Competitive Landscape:

There is fierce competition among well-known firms like Viasonix, Moor Instruments, Vasamed, ELCAT, CorVascular Diagnostics, and others in the global market for skin perfusion pressure testing equipment. To meet the increasing need for precise diagnostic instruments in the treatment of wounds and vascular diseases, these major manufacturers consistently make investments in R&D to improve their product lines for measuring skin perfusion pressure. As businesses seek to increase their geographic reach and product portfolios, market expansion tactics such as partnerships, mergers, and acquisitions are common. In addition, the competitive environment of this market is greatly influenced by regulatory approvals and technology developments, which demonstrate a dedication to enhancing healthcare results. For instance, in July 2023, the Swedish company PeriMed AB, which developed epidermal blood flow monitoring devices, was purchased by Smith & Nephew (UK). Smith & Nephew's current line of wound care products and technologies was enhanced by this acquisition, expanding their offers in the healthcare industry.

Recent Development

February 2024: Leading Nordic healthcare investor Serendipity Partners has purchased a substantial 49% share in Perimed AB, a prominent leader in the vascular medical devices market. This marks a significant milestone for the company. This collaboration guarantees Perimed's ongoing development and product expansion.

January 2023: Vasamed (Sweden), a top producer of skin perfusion pressure testing equipment, was purchased by MicroPort Scientific Corporation (China). Through this transaction, MicroPort gained access to Vasamed's cutting-edge product line and solidified its place in the wound care industry.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SKIN PERFUSION PRESSURE TESTING DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL SKIN PERFUSION PRESSURE TESTING DEVICES MARKET, BY MOBILITY- MARKET ANALYSIS, 2019 - 2032

GLOBAL SKIN PERFUSION PRESSURE TESTING DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL SKIN PERFUSION PRESSURE TESTING DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

GLOBAL SKIN PERFUSION PRESSURE TESTING DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Skin Perfusion Pressure Testing Devices Market Overview

2. Executive Summary

3. Skin Perfusion Pressure Testing Devices Key Market Trends

4. Skin Perfusion Pressure Testing Devices Industry Study

5. Skin Perfusion Pressure Testing Devices Market: COVID-19 Impact Analysis

6. Skin Perfusion Pressure Testing Devices Market Landscape

7. Skin Perfusion Pressure Testing Devices Market - By Mobility

8. Skin Perfusion Pressure Testing Devices Market - By Product

9. Skin Perfusion Pressure Testing Devices Market - By End Use

10. Skin Perfusion Pressure Testing Devices Market- By Geography

11. Key Vendor Analysis- Skin Perfusion Pressure Testing Devices Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â